SynthesisBMC health services research2026
A review of artificial intelligence in healthcare supply chains: untapped potential?
Synthesis in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSupply chain management (SCM) is a central function of operational strategy and provides assurance of continuous delivery of services and products across different industries. While Artificial Intelligence (AI) has transformed SCM in other industries through predictive analytics, its application within healthcare remains poorly defined. We conducted a systematic review to analyse the extent of AI adoption, the specific methodologies employed, and the empirical evidence of its impact on healthcare SCM.
methodsWe performed a systematic review following Cochrane guidelines across MEDLINE (PubMed), LILACS, and SciELO databases up to May 2024. We screened for studies describing AI applications in healthcare SCM. Because of the heterogeneity of the included studies, we applied a narrative synthesis framework. Quality of reporting and evidence maturity were assessed using the STROBE tool. The protocol was registered in PROSPERO (CRD42024528856).
findingsFrom 8,697 initial records, only 13 met the inclusion criteria. The narrative synthesis revealed a significant conceptual gap: most “AI” applications (N = 6) relied on theoretical fuzzy multi-criteria decision making (MCDM) and optimisation logic, rather than data-driven machine learning techniques common in other sectors. The literature is concentrated on supplier selection (N = 4) and logistics simulation. Crucially, none of the studies reported application in real-world settings. STROBE assessment indicated a low maturity of evidence, with consistent lack of reporting on bias and external validity. DISCUSSION: The integration of AI in healthcare SCM is in a theoretical stage. There is a marked disconnect between the computational potential of AI and its actual deployment. Current research is dominated by mathematical simulations of supplier selection rather than operational implementation. The lack of empirical evidence and the reliance on theoretical models highlight a significant “untapped potential” that requires a shift from simulation to real-world validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.